Biocryst Pharmaceuticals buy StockNews.com
Start price
28.06.25
/
50%
€7.92
Target price
28.06.26
-
Performance (%)
9.79%
End price
29.06.26
€8.70
Summary
This prediction ended on 29.06.26 with a price of €8.70. The BUY prediction by StockNews_com finished with a performance of 9.79%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | 1.223% | 1.223% | 13.653% |
| iShares Core DAX® | 2.573% | 5.333% | 8.273% |
| iShares Nasdaq 100 | 4.858% | 0.449% | 27.079% |
| iShares Nikkei 225® | 5.590% | -0.586% | 48.553% |
| iShares S&P 500 | 3.250% | 2.500% | 23.351% |
Comments by StockNews_com for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten